Treatment of Hamstring Muscle in Patients With Low-back Pain
Launched by UNIVERSITY OF ALCALA · Sep 12, 2019
Trial Information
Current as of May 17, 2025
Completed
Keywords
ClinConnect Summary
Shortening of the hamstrings could be related to low back pain.Therefore, the treatment of these muscles may improve pain.
The dry needling technique seems to improve the extensibility of the muscles. This technique seems to be more effective when is applied in the most hyperalgesic areas related to the participant's pain.
In order to demonstrate this hypothesis, the investigators will check if the dry needling technique produces the same effects when is applied in other areas of those same muscles
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Nonspecific chronic low back pain lasting ≥ 3 months.
- • Age between 18 and 65 years.
- • History of non-specific lumbar pain not irradiated to lower extremities of at least 1 year of evolution.
- • Those subjects who have not received a physiotherapy session in the last 6 months.
- Exclusion Criteria:
- • Specific low back pain (infection, tumor, inflammation, canal stenosis, spondylolisthesis, hernia or disc prolapse, structural deformity, rheumatic disease, radicular pain, cauda equina, previous history of spinal surgery).
- • Fibromyalgia.
- • Treatment with corticosteroids or oral medications in the last 6 months.
- • History of spinal surgery.
- • Contraindications typical of deep dry puncture (needle phobia, coagulation or psychological disorders, varicose regions, cysts, wounds, metal or latex allergy, lymphedema, hypothyroidism, diabetes).
- • Those subjects with a value of 0º in the Active Knee Extension (EAR) test.
- • Pregnancy
About University Of Alcala
The University of Alcalá, a prestigious institution located in Spain, is committed to advancing medical research and innovation through its clinical trial sponsorship. With a strong emphasis on interdisciplinary collaboration and ethical standards, the university leverages its academic expertise and state-of-the-art facilities to facilitate groundbreaking studies in various fields of healthcare. By fostering partnerships with industry leaders and healthcare professionals, the University of Alcalá aims to enhance patient outcomes and contribute to the global body of medical knowledge. Its dedication to rigorous research methodologies ensures the integrity and reliability of clinical trials, promoting a culture of excellence in scientific inquiry.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alcalá De Henares, Madrid, Spain
Alcalá De Henares, Madrid, Spain
Patients applied
Trial Officials
Tomas Gallego-Izquierdo, PhD
Study Chair
Alcala University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials